Vaccine Scheduler
Norway: Recommended vaccinations
| General recommendation | |
| Recommendation for specific groups only | |
| Catch-up (e.g. if previous doses missed) | |
| Vaccination not funded by the National Health system | |
| Mandatory vaccination |
| Birth | Weeks | Months | Years | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 | 6 | 3 | 5 | 12 | 15 | 7 | 11 | 12 | 13 | 15 | 18-19 | 25 | 45 | 64 | ≥ 65 | |||||
| tuberculosis | BCG1 | |||||||||||||||||||
| rotavirus infection | RV1 | RV1 | ||||||||||||||||||
| diphtheria | D | D | D | D | d | d2 | ||||||||||||||
| tetanus | TT | TT | TT | TT | TT | TT2 | ||||||||||||||
| pertussis | acP | acP | acP | acP | acP | acp3 | ||||||||||||||
| poliomyelitis | IPV | IPV | IPV | IPV | IPV | IPV2 | ||||||||||||||
| Haemophilus influenzae type b infection | Hib | Hib | Hib | |||||||||||||||||
| hepatitis B | HepB4 | HepB5 | HepB | HepB | HepB | |||||||||||||||
| pneumococcal disease | PCV13 | PCV13 | PCV13 | PCV20 or PPSV236 | PCV20 or PPSV23 | |||||||||||||||
| measles | MEAS | MEAS | ||||||||||||||||||
| mumps | MUMPS | MUMPS | ||||||||||||||||||
| rubella | RUBE | RUBE | ||||||||||||||||||
| human papillomavirus infection | HPV2 (F/M)7 | HPV2 (F/M) | ||||||||||||||||||
| influenza | IIV3/aIIV3 | |||||||||||||||||||
Version:
Footnotes:
- Specific at-risk groups only
- Revaccination every 10 years
- Revaccination every 10 years. Recommendation for vaccination during pregnancy in week 24, but catch-up vaccination can be accommodated until birth. More information available at: https://www.fhi.no/va/kikhostevaksine-til-gravide/ and https://www.fhi.no/contentassets/944632814cbc4260bac97a49924b7884/vedlegg/infoark-engelsk-kikhostevaksine-gravide.pdf
- Babies born to a mother infected with hepatitis B will be offered a dose at birth simultaneously with HB immunoglobulin.
- A second vaccine dose is given at age 4 weeks to those babies born to mothers infected with hepatitis B. These infants thereafter follow the national vaccination programme.
- Fully funded for patients with HIV infections, stem cell transplantations and for anatomical or functional asplenia. Not funded (NF) for other risk groups.
- Gender-neutral (boys and girls) vaccination offered in schools (seventh grade) since 2018. 2-valent
More information available at:
http://www.fhi.no/tema/vaksiner-og-vaksinasjon
All vaccines offered through the Norwegian childhood vaccination program are free of charge.
MAJOR HISTORICAL CHANGES
2006: DTaP at 7 years added to the immunization program in January 2006
2007: Pneumococcal conjugate vaccine added to the childhood immunization program in July 2006
2009: HPV vaccine introduced in the immunization program for 12 year old girls in autumn 2009
2009: BCG at 13-15 years discontinued; starting from autumn 2009 BCG is given only to children at birth in defined risk groups
2011: Prevenar 13 replaced Prevenar in April 2011
2013: TdacP at 15 years added to the immunization program in autumn 2013
2014: Rotavirus introduction (2 doses) for all children born from 01 Sept. 2014
2017: Hepatitis B vaccine introduced as part of the Childhood Immunisation Programme for all children born after November 1st 2016. The first doses were given in February 2017 when they are 3 months old. see https://www.fhi.no/en/news/2016/na-innfores-hepatitt-b-vaksinen-i-barnevaksinasjonsprogrammet/
2018: Gender-neutral HPV vaccination
Date of last update: 29 August 2024.